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and development of a 3 dimensional pericardial
adipose tissue model
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Prashanthan Sanders1 and Joseph B Selvanayagam2*Abstract
Background: Recently pericardial adipose tissue (PAT) has been shown to be an independent predictor of atrial
fibrillation (AF). Atrial PAT may influence underlying atrial musculature creating a substrate for AF. This study sought
to validate the assessment of total and atrial PAT by standard cardiovascular magnetic resonance (CMR) measures
and describe and validate a three dimensional atrial PAT model.
Methods: 10 merino cross sheep underwent CMR using a 1.5 Tesla system (Siemens, Sonata, Erlangen, Germany).
Atrial and ventricular short axis (SA) images were acquired, using ECG -gated steady state free precession
sequences. In order to quantify total volume of adipose tissue, a three dimensional model was constructed from
consecutive end-diastolic images using semi-automated software. Regions of adipose tissue were marked in each
slice followed by linear interpolation of pixel intensities in spaces between consecutive image slices. Total volume
of adipose tissue was calculated as a total volume of the three dimensional model and the mass estimated from
volume measurements. The sheep were euthanized and pericardial adipose tissue was removed and weighed for
comparison to the corresponding CMR measurements.
Results: All CMR adipose tissue estimates significantly correlated with autopsy measurements (ICC > 0.80; p < 0.03).
Intra- observer reliability in CMR measures was high, with 95% levels of agreement within 5.5% (ICC = 0.995) for
total fat mass and its individual atrial (95% CI ± 8.3%, ICC = 0.993) and ventricular components (95% CI ± 6.6%,
ICC = 0.989). Inter- observer 95% limits of agreement were within ± 10.7% (ICC = 0.979), 7.4% (ICC = 0.991) and 7.2%
(ICC = 0.991) for atrial, ventricular and total pericardial adipose tissue, respectively.
Conclusion: This study validates the use of a semi-automated three dimensional atrial PAT model utilizing standard
(clinical) CMR sequences for accurate and reproducible assessment of atrial PAT. The measurement of local cardiac
fat stores via this methodology could provide a sensitive tool to examine the regional effect of fat deposition on
atrial substrate which potentially may influence AF ablation strategies in obese patients.
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The increasing prevalence of atrial fibrillation (AF) has been
in-part attributed to the aging population and its associated
co-morbidities such as hypertension, coronary artery dis-
ease and heart failure. However, there is increasing evidence
that obesity contributes to the burden of atrial fibrillation
in our population. Analyses from the Framingham and
Women Health Studies (WHS) suggest that obesity is asso-
ciated with an increased risk of AF independent of other
traditional risk factors [1,2]. These population-based studies
have utilized body mass index as a measure of obesity. Re-
cently, pericardial adipose tissue (PAT), both total and
atrial, has been demonstrated to predict AF risk independ-
ently of weight and other measures of obesity [3-5]. This
has two important implications. Firstly, PAT could have a
causal relationship with the risk of AF and it has been hy-
pothesized that this effect could be mediated locally [6-8].
Secondly, a change in atrial PAT mass with weight change
could be a better predictor of the risk of AF as compared to
other measures of weight change. Although, ventricular
paracardiac adipose tissue CMR measurement has been val-
idated before, the validation of the patchy and smaller vol-
ume of atrial PAT with the gold standard of mass at
autopsy has not been previously performed [9]. In this study
we sought to validate the quantification of atrial and total
PAT utilizing a three dimensional atrial PAT model.
Methods
Ten merino cross sheep with weight ranging from 67 to
103 kilograms were included in the study. All procedures
were conducted in accordance with the guidelines outlined
in the “Position of the American Heart Association on
Research Animal Use” adopted on November 11, 1984 by
the American Heart Association. The study protocol was
reviewed and approved by the Animal Research Ethics
Committees of University of Adelaide and Institute of
Medical and Veterinary Services, Adelaide, Australia.
Definitions
The fat deposits around the heart have been defined in
this study as:
○ Epicardial adipose tissue was defined as the adipose
tissue between the myocardium and visceral
pericardium [10,11].
○ Paracardiac adipose tissue was defined as the adipose
tissue adherent and external to the parietal
pericardium [12].
○ Pericardial adipose tissue was defined the sum of the
epicardial and paracardiac adipose tissue [13].
Cardiovascular magnetic resonance protocol and analysis
All animals underwent cardiovascular magnetic resonance
(CMR) immediately prior to euthanasia for the evaluationof pericardial adipose tissue. CMR was performed using a
1.5 Tesla system (Siemens, Sonata, Erlangen, Germany).
The animals were anaesthetized and placed supine within
the CMR bore. The animals were mechanically ventilated
to allow breath holding sequences to be performed. Se-
quential steady state free precession (SSFP) short-axis cine
sequences were acquired with 6 mm slice-thickness and
no interslice gaps through both the atrial and the ventri-
cles. Slices were aligned to at 90 degrees to the long axis
of the left ventricle, and planned from the most cranial as-
pect of the left atrium and proceeded caudally to the left
ventricular apex. All images were acquired at end expiration
with the following parameters (slice thickness 6 mm/0 mm,
TR/TE 52.05 ms/1.74 ms, flip angle 70 degree, matrix
256 × 150, FOV 380 mm). In order to replicate standard
clinical protocols, this study intentionally did not incorpor-
ate adipose-specific sequences.
The image analysis was conducted offline using cus-
tom made software. The areas of pericardial adipose tissue
were traced on consecutive end diastolic images (Figure 1).
The ventricular pericardial adipose tissue was defined as
adipose tissue from the mitral valve hinge (point of inser-
tion at the annulus) down to the ventricular apex, inclu-
sive of the most inferior margin of the adipose tissue. The
atrial pericardial adipose tissue was defined as the pericar-
dial adipose tissue lying above the mitral valve hinge and
below the right pulmonary artery. Not all CMR images
were of sufficient quality to adequately define the visceral
pericardium, particularly in atrial slices, and as a result no
attempt was made to differentiate epicardial and para-
cardiac components of adipose tissue.
In order to quantify total volume of adipose tissue, a
three dimensional (3D) model was constructed using semi-
automated software developed by the authors. Regions of
PAT were marked in each slice followed by linear inter-
polation of pixel intensities in spaces between consecutive
image slices. The total fat volume was quantified on the
three dimensional model was converted to mass by multi-
plying it with a density constant of 0.9.
Assessment of atria, ventricular and total cardiac fat
volume measured by CMR scans was performed twice
by the primary investigator to determine intra-observer
measurement error. An additional independent and ex-
perienced investigator also measured the fat volume com-
ponents to establish an inter-observer agreement. All
measures of CMR fat were performed blinded to the aut-
opsy values.
Pericardial fat quantification at autopsy
The sheep were euthanized following acquisition of CMR
images. While the sheep were under general anesthesia,
the heart was surgically removed from the sheep thorax,
with particular attention paid to retrieving all the pericar-
dial adipose tissue. To ensure that all pericardial fat was
Figure 1 Three dimensional model of pericardial adipose tissue using semi-automated in-house software. Adipose tissue was marked on
each slice followed by interpolation of pixel intensities between consecutive slices. A) A three dimensional rendered model of the ventricular
pericardial adipose tissue. B) Short axis view of the left and right ventricles with the pericardial adipose tissue marked in red. C) A three
dimensional model of the atrial pericardial adipose tissue. D) A short axis view of the left and right atrium with the pericardial adipose tissue
marked in red.
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veins, right pulmonary artery and the trachea intact. An
incision was made circumferentially along the atrio-
ventricular groove and the pericardium peeled back to-
wards the apex (Figure 2; Step 2) and collected as the
paracardiac ventricular fat. The remaining pericardium
was peeled upwards toward the pulmonary artery with
all fat up to the pulmonary artery branches being as-
signed to paracardiac atrial fat. After the trachea wasFigure 2 The process of atrial and ventricular pericardial adipose tissue
veins, pulmonary artery and part of trachea, 2) Pericardium incised along the
ventricular apex to harvest paracardiac ventricular adipose tissue and superior
heart after removal of paracardiac adipose tissue, with epicardial atrial adipose
the AV groove, 4) Anterior view of the heart with atrial and ventricular paraca
located between the appendages and the great vessels, with little fat deposit
majority of epicardial adipose tissue.removed from the heart, the fat was then meticulously dis-
sected from the ventricle and atria to collect the epicardial
fat (Figure 2; Step 4). The total pericardial adipose tissue for
the atria and ventricles was calculated as the sum of
paracardiac and epicardial components (Figure 2; Step 5).
Statistical analysis
Normally distributed continuous data are reported as
mean ± standard deviation. The agreement between autopsymeasurement via autopsy. Steps 1) Removal of heart with pulmonary
atrio-ventricular (AV) groove and was peeled off inferiorly to the
ly to harvest atrial paracardiac adipose tissue, 3) Posterior view of the
tissue visible posterior (adjacent to posterior LA wall) and laterally along
rdiac adipose tissue to the left. Atrial paracardiac adipose tissue was
ion on the appendages, 5) Posterior view of the heart after dissecting the
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and those derived from CMR were assessed via intra-class
correlation coefficients (ICC) and Bland and Altman plots
with 95% limits of agreement. Consistency, rather than ab-
solute ICCs were calculated via a two way random effects
model because of the expected systematic bias toward
lower masses on autopsy due to technical limitations in
removing all fat from the ex-vivo heart. The inter- and
intra-observer reliability of CMR fat assessment was as-
sessed using the same methodology, except that consis-
tency ICCs were calculated. All tests were performed
using PASW (Version 18 IBM, Armonk, NY) with p <
0.05 deemed significant.
Results
Ten sheep with a mean weight of 80 ± 8 kg were assessed
for both CMR and autopsy pericardial adipose tissue assess-
ment, however one sheep was excluded from further ana-
lyses due to CMR artifacts precluding accurate assessment.
Mean CMR imaging time was 30 minutes per animal. The
additional mean time duration to assess pericardial adipose
tissue with the semi-automated software was 5 ± 1.4 mi-
nutes per animal. On CMR assessment atrial, ventricular
and total adipose tissue were assessed as 37 ± 10, 250 ± 71,
287 ± 77 g, respectively. On autopsy, the corresponding
values were 29 ± 8, 231 ± 70, 260 ± 74 g. Table 1 shows the
pericardial adipose tissue CMR measures and the corre-
sponding autopsy values.
Autopsy pericardial adipose tissue regional distribution
The atrial epicardial adipose tissue was distributed pre-
dominately adjacent to posterior wall of left atrium and
adjacent to the atrio-ventricular groove. The atrial para-
cardiac adipose tissue deposits were mainly between the
appendages and the great arteries (Figure 2). The ventricu-
lar epicardial adipose tissue was distributed predominately
along the atrio-ventricular groove and the coronary arter-
ies. In contrast, the paracardiac ventricular fat was evenly







1 235 195 40
2 285 265 20
3 414 372 42
4 298 268 30
5 194 172 22
6 253 225 28
7 216 182 34
8 286 260 26
9 160 140 20Agreement of CMR assessment with Autopsy measures of
pericardial adipose tissue
Atrial, ventricular and total CMR pericardial adipose tissue
correlated strongly with autopsy measurements (ICC > 0.80;
p < 0.003) (Figure 3). CMR systematically over-estimated
total autopsy fat by a mean of 26 g, within 95% confidence
limits of ± 23.0 g. The corresponding ventricular and atrial
components were overestimated by a mean of 19.0 g (95%
CI ± 19.5 gms) and 7.7 g (95% CI ± 11.6 gms), respectively.Intra- and inter-observer reliability of CMR assessment of
pericardial adipose tissue
Intra- observer reliability for CMR measured atrial, ven-
tricular and total fat mass assessment measures was high
(ICC > 0.993), with 95% levels of agreement ± 5.5% for total
fat mass, ± 8.3% for atrial fat mass and ± 6.6% for ventricu-
lar mass (Table 2). Similarly, all components of fat measure-
ment (total, ventricular and atrial) ICCs exceeded 0.991 for
inter- observer reliability. The 95% limits of agreement were
within ± 10.7%, ± 7.4% and ± 7.2% for atrial, ventricular and
total pericardial adipose tissue, respectively (Table 3).Discussion
To the best of our knowledge, this is the first study to
validate a CMR technique to specifically assess atrial peri-
cardial adipose tissue. Our findings demonstrate that: [1]
CMR assessment of atrial, ventricular and total fat has high
intra- and inter-observer reproducibility, and [2] CMR
quantified atrial and ventricular adipose tissue strongly
agrees with ex vivo adipose mass, validating its use as a ro-
bust measure of pericardial adiposity. Moreover, the find-
ings were reproducible and the image sequences utilized
were those which would normally be acquired during a
standard clinical CMR scan. Importantly, this study vali-
dates a three dimensional model of atrial pericardial adi-
pose tissue which can be utilized to study regional fat
deposits with respect to underlying atrial electrophysio-


















Figure 3 Agreement of CMR assessment with autopsy measures of pericardial adipose tissue. Panel A shows the limits of agreement (ICC)
between total pericardial adipose tissue measures on Autopsy and CMR. Panel B represents the degree of agreement, via Bland and Altman plots.
Similarly, the panels C, D and E, F represent limits of agreement and Bland and Altman plots for ventricular and atrial pericardial adipose
tissue, respectively.
Mahajan et al. Journal of Cardiovascular Magnetic Resonance 2013, 15:73 Page 5 of 7
http://jcmr-online.com/content/15/1/73
Table 2 Intra-observer reproducibility of CMR measures
of pericardial adipose tissue (PAT)
PAT Intra-observer




Total 15.9 5.5 0.001
Ventricular 16.4 6.6 0.001
Atrial 3.1 8.3 0.003
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previously been utilized for pericardial fat assessment.
However, echocardiography is limited by its inability to
obtain pericardial volumes and often sub-optimal imaging
windows [14]. Moreover, echocardiography has been lim-
ited to assessment of ventricular pericardial adipose tissue.
Although, volumetric assessment of pericardial adipose
tissue can be performed by CT, the exposure to ionizing
radiation limits its use, especially if serial measurements
are planned [15].
Obesity has been demonstrated, in several population
based studies, to be a novel risk factor for atrial fibrilla-
tion [16-19]. Its association with hypertension, obstructive
sleep apnea, diabetes mellitus, coronary artery disease and
congestive heart failure, clouds interpretation of the poten-
tial mechanisms by which obesity is linked to atrial fibrilla-
tion. Population level studies have suggested that the effect
may be mediated through left atrial enlargement [16,17],
albeit evidence is mounting that pericardial adipose tissue,
surrounding the heart, may also play a significant role in
the development of atrial fibrillation. Batal et al suggested
that computed-tomography (CT) measured pericardial fat
thickness is associated with prevalent AF [5]. In partici-
pants of the Framingham Heart Study, a community-based
cohort, Thanassoulis et al observed that higher pericardial
fat volumes were associated with a nearly 40% higher odds
of prevalent AF [3]. Wong et al have recently demonstrated
that pericardial fat volume is a better predictor than body
mass index in predicting severity of atrial fibrillation and
even outcomes after ablation [4]. As adipose tissue is highly
vascular, it is hypothesized that mediators of lipid metabol-
ism and inflammation produced in the pericardial adipose
tissue may affect the underlying atrial myocardium in a
paracrine manner [8]. In addition, epicardial fat has been
demonstrated to infiltrate underlying atrial musculature
in an obese ovine model [20]. This fatty infiltration canTable 3 Inter-observer reproducibility of CMR measures






Total 20.9 7.2 0.001
Ventricular 18.6 7.4 0.001
Atrial 3.9 10.7 0.001mechanically separate muscle fibers and create an area of
electrical silence promoting reentry and atrial fibrillation.
A recent study has reported the association of elevated
dominant frequency with epicardial fat location [21].
This study demonstrates that CMR assessment of peri-
cardial fat is an accurate and reproducible measure that
could be utilized in future larger clinical cohorts. Further-
more, three dimensional PAT model constructed from
CMR slices, allows regional interpretation of local cardiac
fat stores, that in future could be utilized in conjunction
with electro-anatomic maps to investigate the atrial sub-
strate for atrial fibrillation. This could potentially have
implications for planning ablation strategies for atrial
fibrillation ablation in obese individuals.
Ventricular paracardiac adipose tissue has previously
been validated using CMR [9]. This current study, to the
best of our knowledge, is the first to validate CMR mea-
sure of atrial pericardial fat. Furthermore, in the study
by Nelson et al [9], the paracardiac adipose tissue was
validated against the histological gold standard. In con-
trast, in the current study, the total pericardial fat volume
was validated, as the epicardial adipose tissue was meticu-
lously removed along with the paracardiac adipose tissue.
This provided a more accurate comparison between au-
topsy and CMR pericardial adipose tissue measures. How-
ever, complete removal of epicardial adipose tissue was
not possible due to its adherence to underlying myocar-
dium in some cases, and this could be a reason for a small
systematic over-estimation by CMR (Figure 3).
Limitations
Fat suppression sequences were intentionally not performed
in the study as our intention was to validate measurement
of atrial pericardial adipose tissue using a standard clinical
CMR protocol. However, fat suppression sequences could
improve adjudication of adipose tissue and further improve
inter- and intraobserver variability. Furthermore, although
stringent attempts were made to completely remove all
epicardial adipose tissue at autopsy, this was not always
possible.
Clinical implications
With the increasing incidence and burden of atrial fibril-
lation, the identification and characterization of new risk
factors is of public health importance [22]. Atrial PAT
has been demonstrated to predict AF risk independent
of other measures of obesity. Given the dual epidemics
of obesity and atrial fibrillation, non-invasive CMR mea-
surement of atrial PAT could provide incremental infor-
mation on the risk of developing AF. Moreover, atrial
pericardial adipose tissue could provide insights in evalu-
ating the variability of AF risk in obese individuals with
change in weight [2]. The three dimensional model of
pericardial fat validated in this study could be utilized to
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lying atrial myocardium. In addition, the information on
regional interaction of pericardial fat with adjacent atrial
tissue may provide new insights for planning ablation strat-
egies for atrial fibrillation in obese individuals.
Conclusion
CMR measurement of atrial, ventricular and total pericar-
dial adipose tissue via 3D modeling of fat stores is a repro-
ducible and accurate measure of pericardial fat on autopsy.
The measurement of local cardiac fat stores via this meth-
odology could provide a more sensitive tool to examine
the potential causal relationship between obesity and atrial
fibrillation and examine the regional effect of fat depo-
sition on atrial substrate.
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